title: Metabolic effects of dobutamine in normal man.
abstract: 1. Dobutamine in 5% (w/v) D-glucose was infused at sequential doses of 2, 5 and 10 micrograms min-1 kg-1, 45 min at each dose, into eight healthy male subjects, and the effects were compared with those produced by infusion of the corresponding volumes of 5% (w/v) D-glucose alone. 2. The energy expenditure increased and was 33% higher than control (P less than 0.001) at 10 micrograms of dobutamine min-1 kg-1. The respiratory exchange ratio decreased from 0.85 (SEM 0.02) before infusion to 0.80 (SEM 0.01) at 10 micrograms of dobutamine min-1 kg-1, but did not alter during the placebo infusion (P less than 0.001). 3. Plasma noradrenaline concentrations were lower during the dobutamine infusion compared with during the infusion of D-glucose alone (P less than 0.025). Plasma dopamine concentrations remained below 0.1 nmol/l throughout both infusions. 4. Compared with during the placebo infusion, the blood glucose concentration decreased (P less than 0.001), the plasma glycerol and free fatty acid concentrations increased by 150 and 225%, respectively (both P less than 0.001), and the plasma potassium concentration decreased from 3.8 (SEM 0.07) to 3.6 (SEM 0.04) mmol/l (P less than 0.01) during dobutamine infusion. The plasma insulin concentration increased at 2 and 5 micrograms of dobutamine min-1 kg-1 (P less than 0.001) with no further rise at 10 micrograms of dobutamine min-1 kg-1. 5. Compared with during the placebo infusion, the systolic and diastolic blood pressures and the heart rate increased during dobutamine infusion (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Intensive Care Unit, Royal Liverpool Hospital, U.K.
authors.forename: C J
authors.initials: CJ
authors.lastname: Green
authors.forename: R S
authors.initials: RS
authors.lastname: Frazer
authors.forename: S
authors.initials: S
authors.lastname: Underhill
authors.forename: P
authors.initials: P
authors.lastname: Maycock
authors.forename: J A
authors.initials: JA
authors.lastname: Fairhurst
authors.forename: I T
authors.initials: IT
authors.lastname: Campbell
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D004280:Dobutamine / Q000494:pharmacology*; D004573:Electrolytes / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects*; D004837:Epinephrine / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D009638:Norepinephrine / Q000097:blood; D011659:Pulmonary Gas Exchange / Q000187:drug effects*
chemical_list: D001786:Blood Glucose; D004573:Electrolytes; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D004280:Dobutamine; D005990:Glycerol; D009638:Norepinephrine; D004837:Epinephrine